Rasio rega marang bathi eliemtx.com (ELYM)
Risks of delays in the development of neuropsychiatric agents and funding shortages have been partially offset by merger deals. This price chart illustrating trading dynamics with the -5.40 indicator complements data on the recruitment of leading neurobiologists through bonuses and the scientific expertise of top management. Eliem Therapeutics (ELYM) relies on the creation of innovative medications for depression and chronic pain with a gentler impact on the body.
Rincian analitis perusahaan eliemtx.com (ELYM)
- rega pasar lan target rega analis:
- rincian kapitalisasi pasar:
- informasi kapitalisasi buku:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas Eliem Therapeutics|ELYM - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Eliem Therapeutics Inc.|ELYM - Gunggung utang perusahaan|Utang marang modal buku Eliem Therapeutics, Inc.|ELYM - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Eliem Therapeutics|Likuiditas darurat eliemtx.com
- rincian bathi lan kelipatan pasar:
ELYM - Bathi resik perusahaan|Penghasilan resik sing dikarepake Eliem Therapeutics|ELYM - Pangali P/E|Pangali Forward P/E eliemtx.com|ELYM - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Eliem Therapeutics, Inc.|ELYM - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Eliem Therapeutics|ELYM - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan eliemtx.com|ELYM - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Eliem Therapeutics
- statistik dodolan lan pendapatan perusahaan:
Analisis umum perusahaan:Eliem Therapeutics Inc., ELYM
The P/E ratio determines the market value of a single unit of profit, measuring the extent to which investors are overpaying for current earnings. High values signal expectations of expansion, while low values indicate undervaluation or risks. By analyzing the P/E dynamics of an issuer, one can track shifts in capital sentiment regarding future growth rates. For Eliem Therapeutics (ELYM), this indicator remains stable, as the development of drugs for neurological pathologies does not depend on consumer cycles.
Pesaing wigati
Rasio rega marang bathi BIIB|Pangali P/E NBIX|Regencell (RGC) - Rasio kapitalisasi marang bathi resik|Rasio rega marang bathi axsome.com AXSM|Pangali P/E ACADIA Pharmaceuticals ACAD|XENE - Rasio rega marang bathi|Periode bali modal bisnis Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Rasio rega marang bathi|CPRX (Catalyst Pharmaceuticals) - Rasio rega marang bathi|DNLI (denalitherapeutics.com) - Pangali P/E|Pangali rega marang bathi HRMY (Harmony Biosciences Holdings, Inc.)|Pangali P/E BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Nilai perusahaan marang bathi resik|Pangali P/E TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalisasi marang bathi resik|anavex.com - Pangali P/E|Nilai perusahaan marang bathi resik CBLL (CeriBell, Inc.)|PRTA: Pangali P/E|Pangali rega marang bathi ALEC|ANNX (Annexon Biosciences Inc.) - Pangali P/E|omeros.com - Kapitalisasi marang bathi resik|Rasio rega marang bathi Neurogene (NGNE)|Periode bali modal bisnis AC Immune SA|Pangali P/E VYGR (voyagertherapeutics.com)|Pangali P/E Neumora NMRA|Scilex Holding - Pangali P/E|Kapitalisasi marang bathi Tevogen Bio Inc.|Alpha Cognition (ACOG) - Rasio rega marang bathi|cogrx.com (CGTX) - Pangali P/E|Rasio rega marang bathi Inhibikase Therapeutics|Cassava (SAVA) - Periode bali modal bisnis|Rasio rega marang bathi Assertio Therapeutics (ASRT)|Periode bali modal bisnis Coya|Vistagen - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik OVID|Acumen Pharmaceuticals Inc. - Pangali P/E|Kapitalisasi marang bathi CervoMed Inc|ATHE: Pangali P/E|Koefisien rega marang bathi Clene Nanomedicine|Rasio rega marang bathi PepGen Corp|Jupiter Neurosciences (JUNS) - Periode bali modal bisnis|Rasio rega marang bathi Relmada Therapeutics, Inc. (RLMD)|ANVS - Kapitalisasi marang bathi|gracetx.com - Koefisien rega marang bathi|AIFF: Pangali rega marang bathi|Klotho Neurosciences - Pangali P/E|NRSN (NeuroSense Therapeutics Ltd.) - Pangali rega marang bathi|Reviva Pharmaceuticals (RVPH) - Rasio rega marang bathi|MTVA (MetaVia Inc.) - Rasio rega marang bathi|Rasio rega marang bathi NeurAxis, Inc|Rasio rega marang bathi HSDT|Pangali P/E PASG|Periode bali modal bisnis Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Koefisien rega marang bathi|Pangali P/E Athira ATHA|Addex Therapeutics - Pangali P/E|ALZN - Pangali P/E|Cyclerion (CYCN) - Rasio rega marang bathi|Protagenic (PTIX) - Pangali P/E|Rasio rega marang bathi Pasithea|Pangali rega marang bathi CRGT (Cortigent)|Rasio rega marang bathi Avenue Therapeutics (ATXI)|BCLI - Kapitalisasi marang bathi|Pangali P/E CARA (Cara Therapeutics Inc)|CHRO - Koefisien rega marang bathi|Intra-Cellular Therapies Inc. - Pangali P/E|Kapitalisasi marang bathi Longboard Pharmaceuticals Inc|Marinus (MRNS) - Rasio rega marang bathi|NKGN - Periode bali modal bisnis|Rasio rega marang bathi NeuroBo Pharmaceuticals|SAGE: Nilai perusahaan marang bathi resik|Pangali P/E SNPX|Trevena Inc. - Pangali rega marang bathi|Rasio rega marang bathi Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Rasio rega marang bathi|Cerevel Therapeutics - Pangali P/E
